Int. J. Mol. Sci. 2014, 15(3), 3904-3925; doi:10.3390/ijms15033904
Review

Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine

1,5,* email, 2,3email, 1,4email, 1,5email, 2,3email, 1,6email and 1,7,* email
Received: 25 December 2013; in revised form: 7 February 2014 / Accepted: 19 February 2014 / Published: 4 March 2014
(This article belongs to the Special Issue Neuroprotective Strategies 2014)
View Full-Text   |   Download PDF [263 KB, uploaded 19 June 2014]
Abstract: In recent decades, nanotechnology has attracted major interests in view of drug delivery systems and therapies against diseases, such as cancer, neurodegenerative diseases, and many others. Nanotechnology provides the opportunity for nanoscale particles or molecules (so called “Nanomedicine”) to be delivered to the targeted sites, thereby, reducing toxicity (or side effects) and improving drug bioavailability. Nowadays, a great deal of nano-structured particles/vehicles has been discovered, including polymeric nanoparticles, lipid-based nanoparticles, and mesoporous silica nanoparticles. Nanomedical utilizations have already been well developed in many different aspects, including disease treatment, diagnostic, medical devices designing, and visualization (i.e., cell trafficking). However, while quite a few successful progressions on chemotherapy using nanotechnology have been developed, the implementations of nanoparticles on stem cell research are still sparsely populated. Stem cell applications and therapies are being considered to offer an outstanding potential in the treatment for numbers of maladies. Human induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state. Although the exact mechanisms underlying are still unclear, iPSCs are already being considered as useful tools for drug development/screening and modeling of diseases. Recently, personalized medicines have drawn great attentions in biological and pharmaceutical studies. Generally speaking, personalized medicine is a therapeutic model that offers a customized healthcare/cure being tailored to a specific patient based on his own genetic information. Consequently, the combination of nanomedicine and iPSCs could actually be the potent arms for remedies in transplantation medicine and personalized medicine. This review will focus on current use of nanoparticles on therapeutical applications, nanomedicine-based neuroprotective manipulations in patient specific-iPSCs and personalized medicine.
Keywords: induced pluripotent stem cells; personalized medicine; neurodegenerative; nanoparticles
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Jang, S.-F.; Liu, W.-H.; Song, W.-S.; Chiang, K.-L.; Ma, H.-I.; Kao, C.-L.; Chen, M.-T. Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine. Int. J. Mol. Sci. 2014, 15, 3904-3925.

AMA Style

Jang S-F, Liu W-H, Song W-S, Chiang K-L, Ma H-I, Kao C-L, Chen M-T. Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine. International Journal of Molecular Sciences. 2014; 15(3):3904-3925.

Chicago/Turabian Style

Jang, Shih-Fan; Liu, Wei-Hsiu; Song, Wen-Shin; Chiang, Kuan-Lin; Ma, Hsin-I; Kao, Chung-Lan; Chen, Ming-Teh. 2014. "Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine." Int. J. Mol. Sci. 15, no. 3: 3904-3925.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert